Information Library

Results for: High-quality studies - Africa

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • The Contribution of Early-phase Clinical Data to a Drug’s Integrated Cardiac Safety Portfolio

    Hear from the Experts — December 6, 2011
    This article examines the financial and time benefits to incorporating intensive ECG and QT/QTc monitoring in early-phase clinical studies.

  • Quintiles Expands World's Largest Cap-Accredited Lab Network

    Press Release — December 1, 2011 – Continuing the expansion of its Global Laboratories’ capabilities and resources, Quintiles announced the opening of a new, expanded central lab in Centurion, South Africa.

  • Partnering is Key to Maximizing Rewards in Emerging Markets

    Press Release — September 27, 2011 – While biopharmaceutical spending in emerging markets is growing at double-digit rates – much faster than in developed nations – opportunities in “pharmerging” countries must be balanced with accompanying costs and risks of entering new markets.

  • Polish Pharmaceutical and Healthcare Sector

    Media Coverage — September 9, 2011
    To say ‘Sleeping Giant’ about Poland is no longer true claims Wojciech Przybys, VP EMEA and provides a deeper analysis of the polish clinical research

  • Shifting Sands

    Media Coverage — September 2, 2011
    As the pressure to improve the productivity of clinical development programmes mounts on pharmaceutical companies, the current landscape for locating cost-effective clinical trials continues to evolve. One region attracting attention is the Middle East and North Africa.

  • Malaria Prevention in Sub-Saharan Africa

    Case Study — June 24, 2011
    This study enabled us to be involved in bringing a malaria vaccine to Africa which could substantially reduce an infant mortality rate that currently stands

  • Oncology Expertise - Scientific Collaborator for Global Solutions

    Brochure — January 28, 2011
    Whether you wish to use one of our existing assays, need assistance with developing a new assay, or plan to deploy an assay developed by your diagnostic partner, as your collaborator, Quintiles has the scientific expertise, resources, and flexibility to develop the right solution for you.

  • New FDA Guidance on Antidiabetic Therapies

    White Paper — December 11, 2009
    Understanding the FDA Guidance on Assessing Cardiovascular Risks for new Antidiabetic Therapies. Learn what FDA cardiac safety requirements may mean for your development program.

Page 1 of 1 (8 results)

Subscribe to Email Based on Your Interests

Set preferences